http://www.unboundmedicine.com/medline/ebm/research/pemetrexedUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19917871/full_citation/American_Society_of_Clinical_Oncology_Clinical_Practice_Guideline_Update_on_Chemotherapy_for_Stage_IV_Non_Small_Cell_Lung_Cancer_Azzoli CG, Baker S, Temin S, et al. 
American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer. [JOURNAL ARTICLE]
J Clin Oncol 2009 Nov 16.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19900274/full_citation/Late_cutaneous_metastases_to_the_face_from_malignant_pleural_mesothelioma:_A_case_report_and_review_of_the_literature_Elbahaie AM, Kamel DE, Lawrence J, et al. 
Late cutaneous metastases to the face from malignant pleural mesothelioma: A case report and review of the literature. [JOURNAL ARTICLE]
World J Surg Oncol 2009 Nov 9; 7(1):84.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19891055/full_citation/Pemetrexed_approved_for_the_fi_rst_line_treatment_of_non_small_cell_lung_cancer:_summary_of_the_NICE_appraisal_Vrouchou P, Kandaswamy P, George E, et al. 
Pemetrexed approved for the fi rst-line treatment of non-small-cell lung cancer: summary of the NICE appraisal. [News]
Lancet Oncol 2009 Nov; 10(11):1031-2.
Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19879055/full_citation/Second_line_treatment_for_malignant_pleural_mesothelioma_Ceresoli GL, Zucali PA, Gianoncelli L, et al. 
Second-line treatment for malignant pleural mesothelioma. [JOURNAL ARTICLE]
Cancer Treat Rev 2009 Oct 28.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19852529/full_citation/Pemetrexed:_a_review_of_its_use_in_the_management_of_advanced_non_squamous_non_small_cell_lung_cancer_Baldwin CM, Perry CM 
Pemetrexed: a review of its use in the management of advanced non-squamous non-small cell lung cancer. [Journal Article]
Drugs 2009; 69(16):2279-302.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19851525/full_citation/Pemetrexed_as_first_line_therapy_for_non_squamous_non_small_cell_lung_cancer_Ricciardi S, Tomao S, de Marinis F 
Pemetrexed as first-line therapy for non-squamous non-small cell lung cancer. [Journal Article]
Ther Clin Risk Manag 2009.:781-7.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19846990/full_citation/Carboplatin_Pemetrexed_Adjuvant_Chemotherapy_in_Resected_Non_small_Cell_Lung_Cancer__NSCLC_:_A_Phase_II_Study_Karapanagiotou EM, Boura PG, Papamichalis G, et al. 
Carboplatin-Pemetrexed Adjuvant Chemotherapy in Resected Non-small Cell Lung Cancer (NSCLC): A Phase II Study. [Journal Article]
Anticancer Res 2009 Oct; 29(10):4297-301.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19841321/full_citation/Phase_II_Trial_of_Pemetrexed_Plus_Bevacizumab_for_Second_Line_Therapy_of_Patients_With_Advanced_Non_Small_Cell_Lung_Cancer:_NCCTG_and_SWOG_Study_N0426_Adjei AA, Mandrekar SJ, Dy GK, et al. 
Phase II Trial of Pemetrexed Plus Bevacizumab for Second-Line Therapy of Patients With Advanced Non-Small-Cell Lung Cancer: NCCTG and SWOG Study N0426. [JOURNAL ARTICLE]
J Clin Oncol 2009 Oct 19.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19839932/full_citation/The_Role_of_Pemetrexed_Combined_with_Targeted_Agents_for_Non_Small_Cell_Lung_Cancer_Konopa K, Jassem J 
The Role of Pemetrexed Combined with Targeted Agents for Non-Small Cell Lung Cancer. [JOURNAL ARTICLE]
Curr Drug Targets 2009 Sep 19.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19839931/full_citation/Pharmacological_Aspects_of_the_Enzastaurin_Pemetrexed_Combination_in_Non_Small_Cell_Lung_Cancer__NSCLC__Giovannetti E, Honeywell R, Hanauske AR, et al. 
Pharmacological Aspects of the Enzastaurin-Pemetrexed Combination in Non-Small Cell Lung Cancer (NSCLC). [JOURNAL ARTICLE]
Curr Drug Targets 2009 Sep 19.
Abstract | Full Citation | Find Related Articles